Abstract
CpG islands are present in one-half of all human and mouse genes and typically overlap with promoters or exons. We developed a method for high-resolution analysis of the methylation status of CpG islands genome-wide, using arrays of BAC clones and the methylation-sensitive restriction enzyme NotI. Here we demonstrate the accuracy and specificity of the method. By computationally mapping all NotI sites, methylation events can be defined with single-nucleotide precision throughout the genome. We also demonstrate the unique expandability of the array method using a different methylation-sensitive restriction enzyme, BssHII. We identified and validated new CpG island loci that are methylated in a tissue-specific manner in normal human tissues. The methylation status of the CpG islands is associated with gene expression for several genes, including SHANK3, which encodes a structural protein in neuronal postsynaptic densities. Defects in SHANK3 seem to underlie human 22q13 deletion syndrome. Furthermore, these patterns for SHANK3 are conserved in mice and rats.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Okano, M., Bell, D.W., Haber, D.A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).
Trasler, J.M., Trasler, D.G., Bestor, T.H., Li, E. & Ghibu, F. DNA methyltransferase in normal and Dnmtn/Dnmtn mouse embryos. Dev. Dyn. 206, 239–247 (1996).
Chen, R.Z., Pettersson, U., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89–93 (1998).
Maraschio, P., Zuffardi, O., Dalla Fior, T. & Tiepolo, L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J. Med. Genet. 25, 173–180 (1988).
Hansen, R.S. et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 96, 14412–14417 (1999).
Xu, G.L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
McClelland, M. & Ivarie, R. Asymmetrical distribution of CpG in an 'average' mammalian gene. Nucleic Acids Res. 10, 7865–7877 (1982).
Bird, A., Taggart, M., Frommer, M., Miller, O.J. & Macleod, D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40, 91–99 (1985).
Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261–282 (1987).
Larsen, F., Gundersen, G., Lopez, R. & Prydz, H. CpG islands as gene markers in the human genome. Genomics 13, 1095–1107 (1992).
Takai, D. & Jones, P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99, 3740–3745 (2002).
Surani, M.A. Imprinting and the initiation of gene silencing in the germ line. Cell 93, 309–312 (1998).
Gartler, S.M., Dyer, K.A. & Goldman, M.A. Mammalian X chromosome inactivation. Mol. Genet. Med. 2, 121–160 (1992).
Hershko, A.Y., Kafri, T., Fainsod, A. & Razin, A. Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development. Gene 302, 65–72 (2003).
Song, F. et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl. Acad. Sci. USA 102, 3336–3341 (2005).
Rakyan, V.K. et al. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol. 2, e405 (2004).
De Smet, C., Lurquin, C., Lethe, B., Martelange, B. & Boon, T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327–7335 (1999).
Futscher, B.W. et al. Role for DNA methylation in the control of cell type-specific maspin expression. Nat. Genet. 31, 175–179 (2002).
Venter, J.C. et al. The sequence of the human genome. Science 291, 1304–1351 1289 (2001).
Antequera, F. & Bird, A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90, 11995–11999 (1993).
Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207–211 (1998).
Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25, 144–146 (2000).
Hodgson, G. et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459–464 (2001).
Snijders, A.M. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29, 263–264 (2001).
Snijders, A.M. et al. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res. 15, 302–311 (2005).
Ishkanian, A.S. et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat. Genet. 36, 299–303 (2004).
Lindsay, S. & Bird, A.P. Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature 327, 336–338 (1987).
Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132–138 (2000).
Qualmann, B., Boeckers, T.M., Jeromin, M., Gundelfinger, E.D. & Kessels, M.M. Linkage of the actin cytoskeleton to the postsynaptic density via direct interactions of Abp1 with the ProSAP/Shank family. J. Neurosci. 24, 2481–2495 (2004).
Wilson, H.L. et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575–584 (2003).
Watt, J.L. et al. A familial pericentric inversion of chromosome 22 with a recombinant subject illustrating a 'pure' partial monosomy syndrome. J. Med. Genet. 22, 283–287 (1985).
Phelan, M.C. et al. 22q13 deletion syndrome. Am. J. Med. Genet. 101, 91–99 (2001).
Bonaglia, M.C. et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261–268 (2001).
Lippman, Z. et al. Role of transposable elements in heterochromatin and epigenetic control. Nature 430, 471–476 (2004).
Huang, T.H. et al. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030–1034 (1997).
Bernstein, B.E. et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120, 169–181 (2005).
Ehrlich, M. et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues and cells. Nucleic Acids Res. 10, 2709–2721 (1982).
Lorincz, M.C., Dickerson, D.R., Schmitt, M. & Groudine, M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat. Struct. Mol. Biol. 11, 1068–1075 (2004).
Desmet, C. et al. The activation of human gene Mage-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 93, 7149–7153 (1996).
Jain, A.J. et al. Fully automatic quantification of microarray image data. Genome Res. 12, 325–332 (2002).
Ihaka, R. & Gentleman, R. A language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299–314 (1996).
Grunau, C., Clark, S.J. & Rosenthal, A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 29, e65 (2001).
Acknowledgements
We thank J. Nakamura for providing rat tissues. This work was supported by the California Breast Cancer Research Program (T.T.C.), Howard Hughes Medical Institute (P.J.), American Brain Tumor Association (C.H.) and US National Institutes of Health (J.F.C.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
The log2 ratios of cohybridizations of BssHII fragments do not exhibit intensity-dependent effects nor geographic location-specific effects. (PDF 238 kb)
Supplementary Fig. 2
Maps of the chromosomal loci corresponding to BAC clones and their loci that exhibit tissue-specific methylation. (PDF 61 kb)
Supplementary Fig. 3
The tissue-specific CpG island methylation and gene expression of SHANK3 is conserved in rat brain and PBL. (PDF 84 kb)
Supplementary Table 1
Primer sequences and cycling conditions. (PDF 22 kb)
Rights and permissions
About this article
Cite this article
Ching, TT., Maunakea, A., Jun, P. et al. Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat Genet 37, 645–651 (2005). https://doi.org/10.1038/ng1563
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1563
This article is cited by
-
Translational pediatrics: clinical perspective for Phelan–McDermid syndrome and autism research
Pediatric Research (2022)
-
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications
Journal of Neurodevelopmental Disorders (2021)
-
Defective AMPA-mediated synaptic transmission and morphology in human neurons with hemizygous SHANK3 deletion engrafted in mouse prefrontal cortex
Molecular Psychiatry (2021)
-
Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Molecular Autism (2020)
-
Effective BAC clone anchoring with genotyping-by-sequencing and Diversity Arrays Technology in a large genome cereal rye
Scientific Reports (2018)